Astellas and UMN strike preliminary deal for cell cultured flu vaccines

Astellas has signed a memorandum of understanding with UMN Pharma for a licensing deal which will give it access to two of the Japanese venture’s pipeline cell cultured influenza vaccines. A definitive agreement is expected to be finalised in September.